Abstract
STUDY DESIGN: We conducted a historic cohort study of neonates who received platelet transfusions at the National Institute of Perinatology, Mexico City, from January 1997 to May 2000. We obtained descriptive and outcome data, and assessed demographic and laboratory means of predicting “good candidates” for a future recombinant thrombopoietin (rTpo) trial.
RESULTS: A minority of the transfused patients (11.4%) received only one transfusion; the majority (88.6%) received multiple transfusions. Neonates who received one or more platelet transfusions were more likely to die (24.5% mortality) than neonates who received no platelet transfusions (3.7% mortality). Regression analyses indicated that the presence of liver disease was the best predictor of a “good candidate” for rTpo administration.
CONCLUSION: The majority of neonates in our institution who receive platelet transfusions receive multiple, not single, transfusions. Receiving any platelet transfusion is a marker for high risk of death. Neonates with liver disease who receive platelet transfusions might be a reasonable group for a phase I rTpo trial.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Arnett C Thrombocytopenia in the newborn Neonat Network 1998 17 27–33
Sola MC, Del Vecchio A, Rimsza LM Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit Clin Perinatol 2000 27 655–79
Murray NA New concepts in the aetiology and management of neonatal thrombocytopenia Semin Neonatol 1999 4 27–40
Roberts IA, Murray NA Management of thrombocytopenia in neonates Br J Haematol 1999 105 864–70
Sola MC, Christensen RD Use of hemopoietic growth factors in the neonatal intensive care unit J Intensive Care Med 1997 12 187–205
Blanchette VS, Rand ML Platelet disorders in newborn infants: diagnosis and management Semin Perinatol 1997 21 53–62
Murphy S, Nepo A, Sills R Consultation with the specialist: thrombocytopenia Pediatr Rev 1999 20 64–8
Hommans A Thrombocytopenia in the neonate Pediatr Clin North Am 1996 43 737–56
Israels SJ Thrombopoietin and neonatal thrombocytopenia Pediatr Res 2000 47 176–7
Blanchette VS, Kuhne T, Hume H, Hellman J Platelet transfusions therapy in newborn infants Transfus Med Rev 1995 9 215–30
Sola MC, Calhoun DA, Hutson AD, Christensen RD Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic neonates in a neonatal intensive care unit Br J Haematol 1999 104 90–2
Sola MC, Christensen RD, Hutson AD, Tarantal AF Pharmacokinetics, pharmacodynamics, and safety of administering regulated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys Pediatr Res 2000 47 208–14
Strauss RG, Levy GJ, Sotelo-Avila C, et al National survey of neonatal transfusions practices: II. Blood component therapy Pediatrics 1993 91 530–6
Book of Procedures and Neonatology Guidelines. Mexico City, Mexico: National Institute of Perinatology 1998 p. 175
Sainio S, Jarvenpaa AL, Renlund M, Riikonen S, Teramo K, Kekomaki R Thrombocytopenia in term infants: a population-based study Obstet Gynecol 2000 95 441–6
Webb IJ, Anderson KC Risks, costs, and alternatives to platelet transfusions Leuk Lymphoma Res 1999 34 71–84
Sungaran R, Markovich B, Chong BH Localization and regulation of thrombopoietin mRNA in human kidney, liver, bone marrow and spleen using in situ hybridization Blood 1997 89 101–7
Watts TL, Murray NA, Roberts IA Thrombopoietin has a primary role in the regulation of platelet production in preterm babies Pediatr Res 1999 46 28–32
Andrews M, Vegh P, Caco C, et al A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants J Pediatr 1993 123 258–91
Kawasaki T, Takeshita A, Souda K, et al Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis Am J Gastroenterol 1999 94 1918–22
Bussel JB Fetal neonatal thrombocytopenia Thromb Haemostasis 1995 74 426–8
Murray NA, Watts TL, Roberts IA Thrombopoietin in the fetus and neonate Early Hum Dev 2000 59 1–12
Bonfiglio MF, Traeger SM, Kier KL, Martin BR, Hulisz DT, and Verbeck SR Thrombocytopenia in intensive care patients: a comprehensive analysis of risk factors in 314 patients Ann Pharmacother 1995 29 835–42
Author information
Authors and Affiliations
Additional information
Supported in part by NIH grants RR00082 and HL61798.
Division of Neonatology at the National Institute of Perinatology, Mexico City, Mexico
Rights and permissions
About this article
Cite this article
Garcia, M., Duenas, E., Sola, M. et al. Epidemiologic and Outcome Studies of Patients Who Received Platelet Transfusions in the Neonatal Intensive Care Unit. J Perinatol 21, 415–420 (2001). https://doi.org/10.1038/sj.jp.7210566
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7210566
This article is cited by
-
Platelet transfusions in preterm infants: current concepts and controversies—a systematic review and meta-analysis
European Journal of Pediatrics (2023)
-
Role of platelets in neonatal necrotizing enterocolitis
Pediatric Research (2021)
-
Implementation of a neonatal platelet transfusion guideline to reduce non-indicated transfusions using a quality improvement framework
Journal of Perinatology (2021)
-
Neonatal thrombocytopenia—causes and outcomes following platelet transfusions
European Journal of Pediatrics (2018)
-
One size will never fit all: the future of research in pediatric transfusion medicine
Pediatric Research (2014)